Release of Angiogenic Inhibitors for Macular Edema

Award Information
Agency:
Department of Health and Human Services
Amount:
$100,000.00
Program:
SBIR
Contract:
1R43EY015581-01
Solitcitation Year:
2004
Solicitation Number:
PHS2004-2
Branch:
N/A
Award Year:
2004
Phase:
Phase I
Agency Tracking Number:
EY015581
Solicitation Topic Code:
N/A
Small Business Information
CHARLESSON, LLP
CHARLESSON, LLP, BOX 14103, OKLAHOMA CITY, OK, 73113
Hubzone Owned:
N
Woman Owned:
Y
Socially and Economically Disadvantaged:
N
Duns:
N/A
Principal Investigator
 YAN Feng
 (405) 514-6372
 YANFENGGOK@HOTMAIL.COM
Business Contact
Phone: (405) 413-6290
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant) Increased vascular permeability or vascular leakage in the retina is an early and common feature of diabetic retinopathy and can result in diabetic macular edema. Vascular leakage is also responsible for cystoid mac

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government